avapro and lisinopril
avapro has been researched along with lisinopril in 17 studies
Research
Studies (17)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (41.18) | 29.6817 |
2010's | 7 (41.18) | 24.3611 |
2020's | 3 (17.65) | 2.80 |
Authors
Authors | Studies |
---|---|
Abbenante, G; Fairlie, DP; Leung, D | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Dive, A; Mwenge, GB; Schoevaerdts, D; Spinewine, A; Swine, C | 1 |
de Zeeuw, D; Navis, G; Vogt, L | 1 |
Coleman, CI; Kluger, J; Makanji, S; White, CM | 1 |
Mailloux, D; McCabe, J; Stork, C; Su, M | 1 |
Ali, K; Bulpitt, CJ; Fantin, F; Rajkumar, C; Schiff, R | 1 |
Buyukhatipoglu, H; Kilisli, H; Sayiner, ZA; Tiryaki, O; Usalan, C | 1 |
Barrio, V; Cachofeiro, V; de Vinuesa, SG; Fernandez Juarez, G; Fernández Vega, F; Goicoechea, M; Gutierrez, E; Luño, J; Nieto, J; Praga, M; Tato, A | 1 |
Li, LJ; Tang, WL; Wang, GM; Wright, JM | 1 |
Attakora, J; Donkoh, IE; Ephraim, RKD; Essuman, G; Okyere, I; Okyere, P; Serwaa, D | 1 |
Reviews
3 review(s) available for avapro and lisinopril
Article | Year |
---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
Topics: Aged; Amides; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Cause of Death; Female; Fumarates; Heart Rate; Humans; Irbesartan; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Myocardial Infarction; Patient Dropouts; Ramipril; Randomized Controlled Trials as Topic; Renin | 2020 |
Trials
3 trial(s) available for avapro and lisinopril
Article | Year |
---|---|
Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?
Topics: Adolescent; Adult; Aged; Biological Availability; Biphenyl Compounds; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Irbesartan; Kidney Diseases; Kidney Function Tests; Lisinopril; Male; Maximum Tolerated Dose; Middle Aged; Patient Selection; Probability; Proteinuria; Renin-Angiotensin System; Risk Assessment; Severity of Illness Index; Tetrazoles; Treatment Outcome; Urinalysis | 2005 |
Irbesartan improves arterial compliance more than lisinopril.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Biphenyl Compounds; Blood Pressure; Carotid Arteries; Compliance; Cross-Over Studies; Double-Blind Method; Female; Femoral Artery; Humans; Hypertension; Irbesartan; Lisinopril; Male; Middle Aged; Radial Artery; Tetrazoles; Treatment Outcome | 2009 |
Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Humans; Irbesartan; Lisinopril; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles | 2013 |
Other Studies
11 other study(ies) available for avapro and lisinopril
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Drug-induced lithium intoxication: a case report.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antipsychotic Agents; Biphenyl Compounds; Drug Interactions; Female; Humans; Irbesartan; Lisinopril; Lithium; Risperidone; Tetrazoles | 2005 |
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Biphenyl Compounds; Cardiac Surgical Procedures; Cohort Studies; Female; Humans; Irbesartan; Lisinopril; Male; Postoperative Complications; Ramipril; Retrospective Studies; Tetrazoles; Valine; Valsartan | 2007 |
Penile angioedema associated with the use of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers.
Topics: Aged; Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Enalapril; Glucocorticoids; Humans; Irbesartan; Lisinopril; Male; Middle Aged; Penis; Prednisone; Tetrazoles | 2008 |
Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Case-Control Studies; Endothelium, Vascular; Female; Fibrinolysis; Humans; Hypertension; Irbesartan; Lisinopril; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Tetrazoles | 2012 |
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana.
Topics: Adult; Aspirin; Bisoprolol; Conservative Treatment; Furosemide; Ghana; Humans; Irbesartan; Kidney Failure, Chronic; Lisinopril; Metformin; Middle Aged; Nifedipine; Ranitidine; Renal Replacement Therapy; Retrospective Studies; Sodium | 2022 |